Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Rounds in the General Hospital

PCC
Clozapine: Its Use and Monitoring
PCC
Pharmacologic Management of TBI
PCC
Evaluation and Management of Treatment-Resistant Schizophrenia
PCC
Neuropsychiatric Complications of Hypervitaminosis D
PCC
Impact of Disability on Medical Care
PCC
Management of Rumination and Obsessions in Primary Care

Page 31

More PCC Articles

JCP
Telehealth vs Face-to-Face Management for PTSD in Primary Care
JCP
Clozapine Use in Singapore and Hong Kong
JCP
Measurement-Based Care for Depressive Disorders: Meta-Analysis of RCTs Shows Efficacy
JCP
Youth Aware of Mental Health (YAM) Intervention
JCP
Eating Disorders in Youth With Bipolar Disorder
JCP
Antipsychotic Efficacy of KarXT (Xanomeline−Trospium)
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ May 11, 2022

This post hoc analysis of phase 2 data evaluated rates and time course of response with the new combination oral agent KarXT (xanomeline−trospium) in the treatment of schizophrenia.
JCP
Daily Dose Effects of Risperidone on Metabolic Parameters
JCP
Corrigendum to “Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials”
JCP
A Practical Guide for Tailoring Treatment Choices in Interventional Psychiatry
JCP
Epilepsy and Suicide Attempt
JCP
Receipt of Antidepressants and Retention in Buprenorphine Treatment for OUD
JCP
Peer-Delivered Psychotherapy for Postpartum Depression: Reply to Tomfohr-Madsen et al